Clinician Quick Reference
Home›Clinicians›AMH testing — rebate criteria & evidence

AMH testing — rebate criteria & evidence

Patient asking for a "fertility check"? What Medicare will cover, and what the evidence actually supports telling them.

Quick rebate check
Why are you ordering AMH?

What the evidence actually shows

This matters because AMH is widely marketed direct-to-consumer as an "egg-timer" or general fertility check — but that's not what the evidence supports:

Practical implication: a "low" AMH in an asymptomatic woman with regular cycles doesn't tell her she can't conceive naturally, and shouldn't be presented that way. A "reassuring" AMH shouldn't be used to delay appropriate fertility-seeking behaviour either (age remains the dominant factor). The main evidence-based use of AMH outside PCOS/POI/oncology contexts is IVF stimulation planning under specialist care.

Handling the "I just want to know my fertility" request

A common, low-friction scenario following direct-to-consumer marketing and social media awareness campaigns:

Practical test notes

Sources: RANZCOG · ASRM Committee Opinion 2020 · MBS/Medicare rebate criteria as documented by pathology providers, current 2026 evidence on AMH and spontaneous conception rates. Verified July 2026 — confirm current Medicare rebate criteria and pricing with your local pathology provider before ordering.
General information only — not clinical advice. This page summarises publicly available evidence and Medicare rebate patterns. It does not replace current guidelines, specialist input, or your own clinical judgement for an individual patient.
You might also like